NanoVibronix, Inc. (NAOV)
USD 2.32
(-9.38%)
USD 2.32
(-9.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.43 Million USD | 31.44% |
| 2022 | -5.01 Million USD | 11.81% |
| 2021 | -5.68 Million USD | -20.43% |
| 2020 | -4.71 Million USD | 8.39% |
| 2019 | -5.15 Million USD | -19.71% |
| 2018 | -4.3 Million USD | -39.21% |
| 2017 | -3.09 Million USD | -33.46% |
| 2016 | -2.31 Million USD | -62.64% |
| 2015 | -1.42 Million USD | -17.59% |
| 2014 | -1.21 Million USD | -9.1% |
| 2013 | -1.11 Million USD | -43.41% |
| 2012 | -774 Thousand USD | -13.49% |
| 2011 | -682 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -674 Thousand USD | -18.66% |
| 2024 Q1 | -568 Thousand USD | 19.09% |
| 2023 Q2 | -1 Million USD | 4.36% |
| 2023 Q1 | -1.05 Million USD | 38.23% |
| 2023 Q3 | -670 Thousand USD | 33.6% |
| 2023 Q4 | -702 Thousand USD | -4.78% |
| 2023 FY | -3.43 Million USD | 31.44% |
| 2022 Q1 | -1.13 Million USD | 54.66% |
| 2022 Q2 | -1.26 Million USD | -11.42% |
| 2022 Q3 | -924 Thousand USD | 27.13% |
| 2022 Q4 | -1.7 Million USD | -84.85% |
| 2022 FY | -5.01 Million USD | 11.81% |
| 2021 Q1 | -1.31 Million USD | 14.68% |
| 2021 Q3 | -868 Thousand USD | 12.41% |
| 2021 Q4 | -2.51 Million USD | -189.17% |
| 2021 Q2 | -991 Thousand USD | 24.58% |
| 2021 FY | -5.68 Million USD | -20.43% |
| 2020 Q4 | -1.54 Million USD | -91.54% |
| 2020 Q2 | -1.46 Million USD | -61.85% |
| 2020 FY | -4.71 Million USD | 8.39% |
| 2020 Q1 | -907 Thousand USD | 26.8% |
| 2020 Q3 | -804 Thousand USD | 45.23% |
| 2019 Q1 | -2.22 Million USD | -63.1% |
| 2019 FY | -5.15 Million USD | -19.71% |
| 2019 Q4 | -1.23 Million USD | -56.24% |
| 2019 Q3 | -793 Thousand USD | 11.5% |
| 2019 Q2 | -896 Thousand USD | 59.69% |
| 2018 Q3 | -1.32 Million USD | -60.73% |
| 2018 FY | -4.3 Million USD | -39.21% |
| 2018 Q1 | -790 Thousand USD | 22.32% |
| 2018 Q2 | -825 Thousand USD | -4.43% |
| 2018 Q4 | -1.36 Million USD | -2.79% |
| 2017 FY | -3.09 Million USD | -33.46% |
| 2017 Q1 | -802 Thousand USD | 4.64% |
| 2017 Q2 | -660 Thousand USD | 17.71% |
| 2017 Q3 | -613 Thousand USD | 7.12% |
| 2017 Q4 | -1.01 Million USD | -65.91% |
| 2016 Q1 | -474 Thousand USD | -3.04% |
| 2016 FY | -2.31 Million USD | -62.64% |
| 2016 Q4 | -841 Thousand USD | -54.31% |
| 2016 Q3 | -545 Thousand USD | -19.52% |
| 2016 Q2 | -456 Thousand USD | 3.8% |
| 2015 FY | -1.42 Million USD | -17.59% |
| 2015 Q1 | -311 Thousand USD | -10.68% |
| 2015 Q2 | -315 Thousand USD | -1.29% |
| 2015 Q3 | -338 Thousand USD | -7.3% |
| 2015 Q4 | -460 Thousand USD | -36.09% |
| 2014 Q4 | -281 Thousand USD | 45.75% |
| 2014 FY | -1.21 Million USD | -9.1% |
| 2014 Q1 | -144 Thousand USD | 23.81% |
| 2014 Q2 | -268 Thousand USD | -86.11% |
| 2014 Q3 | -518 Thousand USD | -93.28% |
| 2013 Q4 | -189 Thousand USD | 5.03% |
| 2013 Q3 | -199 Thousand USD | 0.0% |
| 2013 FY | -1.11 Million USD | -43.41% |
| 2013 Q1 | -661 Thousand USD | -554.46% |
| 2012 FY | -774 Thousand USD | -13.49% |
| 2012 Q4 | -101 Thousand USD | 60.24% |
| 2012 Q3 | -254 Thousand USD | 0.0% |
| 2011 FY | -682 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 76.074% |
| Cerus Corporation | -30.05 Million USD | 88.567% |
| OrthoPediatrics Corp. | -25.76 Million USD | 86.665% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 67.65% |
| Talis Biomedical Corporation | -66.81 Million USD | 94.857% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 80.134% |
| Inogen, Inc. | -109.38 Million USD | 96.859% |
| Spectral AI, Inc. | -12.98 Million USD | 73.537% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 94.51% |
| CVRx, Inc. | -43.1 Million USD | 92.028% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 2.608% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 72.353% |
| Orthofix Medical Inc. | -139.11 Million USD | 97.53% |
| Venus Concept Inc. | -28.3 Million USD | 87.863% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 93.64% |
| Bioventus Inc. | -81.72 Million USD | 95.796% |
| BrainsWay Ltd. | -4.92 Million USD | 30.262% |
| Envoy Medical, Inc. | -18.37 Million USD | 81.297% |
| electroCore, Inc. | -18.8 Million USD | 81.728% |
| IceCure Medical Ltd | -15.57 Million USD | 77.94% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 92.913% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 80.102% |
| MaxCyte, Inc. | -48.29 Million USD | 92.886% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 71.259% |
| Nexalin Technology, Inc. | -5.69 Million USD | 39.68% |
| PAVmed Inc | -68.79 Million USD | 95.005% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 93.925% |
| RxSight, Inc. | -50.08 Million USD | 93.14% |
| Sight Sciences, Inc. | -57.27 Million USD | 94.001% |
| SI-BONE, Inc. | -46.93 Million USD | 92.679% |
| TELA Bio, Inc. | -44.07 Million USD | 92.204% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 93.655% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 93.319% |
| LivaNova PLC | -68.49 Million USD | 94.984% |
| 908 Devices Inc. | -42.75 Million USD | 91.964% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 98.018% |
| Nemaura Medical Inc. | -9.59 Million USD | 64.191% |
| NeuroPace, Inc. | -27.17 Million USD | 87.356% |
| LENSAR, Inc. | -12.22 Million USD | 71.903% |
| Apyx Medical Corporation | -17.25 Million USD | 80.092% |
| Cutera, Inc. | -156.23 Million USD | 97.801% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 60.065% |
| BioSig Technologies, Inc. | -28.51 Million USD | 87.949% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 96.079% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 84.692% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 103.081% |
| Axonics, Inc. | -26.05 Million USD | 86.814% |
| Outset Medical, Inc. | -169.77 Million USD | 97.976% |
| IRIDEX Corporation | -10 Million USD | 65.664% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 96.853% |
| IRadimed Corporation | 20.03 Million USD | 117.15% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 58.326% |
| INVO Bioscience, Inc. | -6.76 Million USD | 49.225% |
| Telesis Bio, Inc. | -35.15 Million USD | 90.225% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 123.978% |
| Varex Imaging Corporation | 32.1 Million USD | 110.704% |
| Quipt Home Medical Corp. | 3.91 Million USD | 187.675% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 71.681% |
| Pulmonx Corporation | -61.93 Million USD | 94.452% |
| Dynatronics Corporation | -2.27 Million USD | -51.163% |
| Modular Medical, Inc. | -17.52 Million USD | 80.398% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 76.528% |
| Semler Scientific, Inc. | 22.25 Million USD | 115.439% |
| InMode Ltd. | 195.66 Million USD | 101.756% |
| Bruker Corporation | 436.9 Million USD | 100.786% |
| Cytosorbents Corporation | -31.2 Million USD | 88.99% |
| DexCom, Inc. | 597.7 Million USD | 100.575% |
| Align Technology, Inc. | 643.33 Million USD | 100.534% |
| Viveve Medical, Inc. | -21.55 Million USD | 84.058% |
| ZimVie Inc. | -30.93 Million USD | 88.894% |
| Movano Inc. | -29.69 Million USD | 88.427% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 87.66% |
| Nexalin Technology, Inc. | -5.69 Million USD | 39.68% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 2.608% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 98.527% |
| Profound Medical Corp. | -28.61 Million USD | 87.993% |
| Insulet Corporation | 220 Million USD | 101.562% |
| enVVeno Medical Corporation | -25.23 Million USD | 86.386% |
| Surmodics, Inc. | -5.64 Million USD | 39.132% |
| iCAD, Inc. | -7.68 Million USD | 55.313% |
| Nuwellis, Inc. | -17.63 Million USD | 80.51% |
| Biotricity, Inc. | -8.82 Million USD | 61.08% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 97.255% |
| Aethlon Medical, Inc. | -12.63 Million USD | 72.809% |
| InspireMD, Inc. | -21.14 Million USD | 83.749% |
| PAVmed Inc. | -68.79 Million USD | 95.005% |
| BIOLASE, Inc. | -17.93 Million USD | 80.844% |
| Beyond Air, Inc. | -63 Million USD | 94.547% |
| FONAR Corporation | 16.53 Million USD | 120.78% |
| AxoGen, Inc. | -21.46 Million USD | 83.99% |
| Vivani Medical, Inc. | -26.96 Million USD | 87.258% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 119.046% |
| Inari Medical, Inc. | -14.03 Million USD | 75.513% |
| UFP Technologies, Inc. | 57.66 Million USD | 105.959% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 30.27% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 45.51% |
| Tenon Medical, Inc. | -15.72 Million USD | 78.152% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 54.027% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 91.954% |
| AdaptHealth Corp. | -598.4 Million USD | 99.426% |
| Sintx Technologies, Inc. | -13.35 Million USD | 74.278% |
| Quanterix Corporation | -49.7 Million USD | 93.087% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 71.681% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -799.476% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 98.973% |
| TransMedics Group, Inc. | -28.72 Million USD | 88.039% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 85.448% |
| NeuroMetrix, Inc. | -7.15 Million USD | 51.954% |
| Hyperfine, Inc. | -48.11 Million USD | 92.859% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 94.716% |
| Biomerica, Inc. | -6.36 Million USD | 46.034% |
| Bone Biologics Corporation | -9.42 Million USD | 63.557% |
| AVITA Medical, Inc. | -40.4 Million USD | 91.495% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 66.677% |
| Silk Road Medical, Inc | -59.27 Million USD | 94.203% |